According to the announcement of Magic Pharmaceuticals, from January to September 2026, it achieved main business revenue of 1,249 billion yuan, a year-on-year decrease of 10.62%; the gross profit margin of the main business was 44.37%, a year-on-year decrease of 2.69 percentage points. By industry, pharmaceutical manufacturing revenue was 675 million yuan, down 17.05% year on year; pharmaceutical commercial revenue was 574 million yuan, down 1.64% year on year. By region, export revenue increased 147.41% year over year, while Southwest China and South China increased by 3.75% and 1.16% respectively. Revenue declined to varying degrees in the rest of the regions.

According to the announcement of Magic Pharmaceuticals, from January to September 2026, it achieved main business revenue of 1,249 billion yuan, a year-on-year decrease of 10.62%; the gross profit margin of the main business was 44.37%, a year-on-year decrease of 2.69 percentage points. By industry, pharmaceutical manufacturing revenue was 675 million yuan, down 17.05% year on year; pharmaceutical commercial revenue was 574 million yuan, down 1.64% year on year. By region, export revenue increased 147.41% year over year, while Southwest China and South China increased by 3.75% and 1.16% respectively. Revenue declined to varying degrees in the rest of the regions.